BACKGROUND: The objective of this study was to identify specific factors (sex, race or ethnicity, and health care provider type) associated with patient receipt of an opioid prescription after a dental diagnosis. METHODS: The authors used Medicaid claims dated from January 1, 2013, through September 30, 2015, for 13 US states in this study. The authors identified oral health-related conditions by using International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes 520.0 through 529.9. RESULTS: During the 2013-2015 study period, among the more than 890,000 Medicaid patients with a dental diagnosis, 23% received an opioid within 14 days of diagnosis. Female patients were 50% more likely to receive an opioid for pain management of a dental condition than were men (odds ratio [OR], 1.53; 95% confidence interval [CI], 1.52 to 1.55). Non-Hispanic whites and African Americans were approximately twice as likely to receive opioids than were Hispanics (OR, 2.11; 95% CI, 2.05 to 2.17 and OR, 1.88; 95% CI, 1.83 to 1.93, respectively). Patients receiving oral health care in an emergency department were nearly 5 times more likely to receive an opioid prescription than were patients treated in a dental office (OR, 4.66; 95% CI, 4.59 to 4.74). Patients with a dental condition diagnosed were nearly 3 times as likely to receive an opioid from a nurse practitioner as from a dentist (OR, 2.64; 95% CI, 2.57 to 2.70). Opioid use was substantially higher among African American female patients (OR, 3.29; 95% CI, 3.18 to 3.40) and non-Hispanic white female patients (OR, 3.24; 95% CI, 3.14 to 3.35) than among Hispanic female patients. CONCLUSIONS: Opioid prescribing patterns differ depending on patient race or ethnicity, sex, and health care provider source in patients with a dental diagnosis in the United States. PRACTICAL IMPLICATIONS: Dentists are providing substantially less opioid prescriptions compared to their medical colleagues for pain treatment following a dental diagnosis in the Medicaid population. When considering pain management for dental and related conditions, dentists should continue with conservative prescribing practices as recommended.
BACKGROUND: The objective of this study was to identify specific factors (sex, race or ethnicity, and health care provider type) associated with patient receipt of an opioid prescription after a dental diagnosis. METHODS: The authors used Medicaid claims dated from January 1, 2013, through September 30, 2015, for 13 US states in this study. The authors identified oral health-related conditions by using International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes 520.0 through 529.9. RESULTS: During the 2013-2015 study period, among the more than 890,000 Medicaid patients with a dental diagnosis, 23% received an opioid within 14 days of diagnosis. Female patients were 50% more likely to receive an opioid for pain management of a dental condition than were men (odds ratio [OR], 1.53; 95% confidence interval [CI], 1.52 to 1.55). Non-Hispanic whites and African Americans were approximately twice as likely to receive opioids than were Hispanics (OR, 2.11; 95% CI, 2.05 to 2.17 and OR, 1.88; 95% CI, 1.83 to 1.93, respectively). Patients receiving oral health care in an emergency department were nearly 5 times more likely to receive an opioid prescription than were patients treated in a dental office (OR, 4.66; 95% CI, 4.59 to 4.74). Patients with a dental condition diagnosed were nearly 3 times as likely to receive an opioid from a nurse practitioner as from a dentist (OR, 2.64; 95% CI, 2.57 to 2.70). Opioid use was substantially higher among African American female patients (OR, 3.29; 95% CI, 3.18 to 3.40) and non-Hispanic white female patients (OR, 3.24; 95% CI, 3.14 to 3.35) than among Hispanic female patients. CONCLUSIONS: Opioid prescribing patterns differ depending on patient race or ethnicity, sex, and health care provider source in patients with a dental diagnosis in the United States. PRACTICAL IMPLICATIONS: Dentists are providing substantially less opioid prescriptions compared to their medical colleagues for pain treatment following a dental diagnosis in the Medicaid population. When considering pain management for dental and related conditions, dentists should continue with conservative prescribing practices as recommended.
Authors: Matthew Daubresse; Hsien-Yen Chang; Yuping Yu; Shilpa Viswanathan; Nilay D Shah; Randall S Stafford; Stefan P Kruszewski; G Caleb Alexander Journal: Med Care Date: 2013-10 Impact factor: 2.983
Authors: James A Feinstein; Jonathan Rodean; Matt Hall; Stephanie K Doupnik; James C Gay; Jessica L Markham; Jessica L Bettenhausen; Julia Simmons; Brigid Garrity; Jay G Berry Journal: Pediatrics Date: 2019-06 Impact factor: 7.124
Authors: Enihomo Obadan-Udoh; Nicoleta Lupulescu-Mann; Christina J Charlesworth; Ulrike Muench; Matthew Jura; Hyunjee Kim; Eli Schwarz; Elizabeth Mertz; Benjamin C Sun Journal: J Am Dent Assoc Date: 2019-04 Impact factor: 3.634
Authors: Chandrashekar Janakiram; Paul Fontelo; Vojtech Huser; Natalia I Chalmers; Gabriela Lopez Mitnik; Avery R Brow; Timothy J Iafolla; Bruce A Dye Journal: Am J Prev Med Date: 2019-08-01 Impact factor: 5.043
Authors: Cecile A Feldman; Janine Fredericks-Younger; Shou-En Lu; Paul J Desjardins; Hans Malmstrom; Michael Miloro; Gary Warburton; Brent Ward; Vincent Ziccardi; Daniel Fine Journal: Trials Date: 2022-02-17 Impact factor: 2.279
Authors: O A Farooqi; W E Bruhn; M K Lecholop; D Velasquez-Plata; J G Maloney; S Rizwi; R B Templeton; A Goerig; C Hezkial; C M Novince; M T Zieman; A M N Lotesto; M A Makary Journal: Int J Oral Maxillofac Surg Date: 2019-10-12 Impact factor: 2.789
Authors: Rebecca M Roberts; Michele K Bohm; Monina G Bartoces; Katherine E Fleming-Dutra; Lauri A Hicks; Natalia I Chalmers Journal: J Am Dent Assoc Date: 2020-01-17 Impact factor: 3.454